Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.

These results suggest that MDMA/ecstasy and psilocybin use is associated with lower risk of depression. Experimental studies are needed to test whether there is a causal association between use of these compounds and the alleviation of depressive symptoms.